<?xml version="1.0" encoding="UTF-8"?>
<ref id="B91-pharmaceuticals-12-00157">
 <label>91.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Watterson</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Modhiran</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Young</surname>
    <given-names>P.R.</given-names>
   </name>
  </person-group>
  <article-title>The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design</article-title>
  <source>Antivir. Res.</source>
  <year>2016</year>
  <volume>130</volume>
  <fpage>7</fpage>
  <lpage>18</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2016.02.014</pub-id>
  <?supplied-pmid 26944216?>
  <pub-id pub-id-type="pmid">26944216</pub-id>
 </element-citation>
</ref>
